Summary
It has been estimated a threefold increase in the number of obese people in Europe since the 1980’s. Currently, EU
countries spend an average of 7% of their public health budgets on diseases linked to obesity. The socio-economic impact of
obesity epidemic cannot be overrated. European societal needs require desperately a shift forward in the field of obesity
research to be able to build new therapeutics strategies. Recent scientific evidences point toward a role of epigenetic
changes as major contributor in the obesity etiology. In the last decades, a huge amount of data clearly link epigenetic
dysregulation to obesity onset. Yet, it remains unclear whether epigenetic dysregulation contributes meaningfully to obesity
epidemic. Because weight gain only occurs when energy intake exceed energy expenditure, burning off excess fuel
represent an attractive path to reduce obesity when diet and exercise are not enough. My preliminary data indicate the
histone methyltransferases Suv420h1 and Suv420h2 as pivotal players in metabolism regulation. By using knockout mice
specifically in brown adipose tissue, this project aims at dissecting the role of Suv420h proteins in the etiology of
obesity. I will combine in vivo and in vitro analyses and genome wide studies to: 1) dissect the role of Suv420h proteins
in the epigenetic regulation of the pathways controlling weight balance in response to nutritional or environmental stimuli; 2) identify genes involved in the generation, maintenance or transmission of the epigenetic memory of exposure; 3) provide useful markers or therapeutic targets to treat obesity and metabolic diseases. My results have the potential to translate into therapeutics. This research will contribute to provide new clinical targets against obesity. The Experienced Researcher will emerge from the project with new skills, and the capability to lead her own research group.
countries spend an average of 7% of their public health budgets on diseases linked to obesity. The socio-economic impact of
obesity epidemic cannot be overrated. European societal needs require desperately a shift forward in the field of obesity
research to be able to build new therapeutics strategies. Recent scientific evidences point toward a role of epigenetic
changes as major contributor in the obesity etiology. In the last decades, a huge amount of data clearly link epigenetic
dysregulation to obesity onset. Yet, it remains unclear whether epigenetic dysregulation contributes meaningfully to obesity
epidemic. Because weight gain only occurs when energy intake exceed energy expenditure, burning off excess fuel
represent an attractive path to reduce obesity when diet and exercise are not enough. My preliminary data indicate the
histone methyltransferases Suv420h1 and Suv420h2 as pivotal players in metabolism regulation. By using knockout mice
specifically in brown adipose tissue, this project aims at dissecting the role of Suv420h proteins in the etiology of
obesity. I will combine in vivo and in vitro analyses and genome wide studies to: 1) dissect the role of Suv420h proteins
in the epigenetic regulation of the pathways controlling weight balance in response to nutritional or environmental stimuli; 2) identify genes involved in the generation, maintenance or transmission of the epigenetic memory of exposure; 3) provide useful markers or therapeutic targets to treat obesity and metabolic diseases. My results have the potential to translate into therapeutics. This research will contribute to provide new clinical targets against obesity. The Experienced Researcher will emerge from the project with new skills, and the capability to lead her own research group.
Unfold all
/
Fold all
More information & hyperlinks
| Web resources: | https://cordis.europa.eu/project/id/746974 |
| Start date: | 01-07-2017 |
| End date: | 01-12-2019 |
| Total budget - Public funding: | 168 277,20 Euro - 168 277,00 Euro |
Cordis data
Original description
It has been estimated a threefold increase in the number of obese people in Europe since the 1980’s. Currently, EUcountries spend an average of 7% of their public health budgets on diseases linked to obesity. The socio-economic impact of
obesity epidemic cannot be overrated. European societal needs require desperately a shift forward in the field of obesity
research to be able to build new therapeutics strategies. Recent scientific evidences point toward a role of epigenetic
changes as major contributor in the obesity etiology. In the last decades, a huge amount of data clearly link epigenetic
dysregulation to obesity onset. Yet, it remains unclear whether epigenetic dysregulation contributes meaningfully to obesity
epidemic. Because weight gain only occurs when energy intake exceed energy expenditure, burning off excess fuel
represent an attractive path to reduce obesity when diet and exercise are not enough. My preliminary data indicate the
histone methyltransferases Suv420h1 and Suv420h2 as pivotal players in metabolism regulation. By using knockout mice
specifically in brown adipose tissue, this project aims at dissecting the role of Suv420h proteins in the etiology of
obesity. I will combine in vivo and in vitro analyses and genome wide studies to: 1) dissect the role of Suv420h proteins
in the epigenetic regulation of the pathways controlling weight balance in response to nutritional or environmental stimuli; 2) identify genes involved in the generation, maintenance or transmission of the epigenetic memory of exposure; 3) provide useful markers or therapeutic targets to treat obesity and metabolic diseases. My results have the potential to translate into therapeutics. This research will contribute to provide new clinical targets against obesity. The Experienced Researcher will emerge from the project with new skills, and the capability to lead her own research group.
Status
CLOSEDCall topic
MSCA-IF-2016Update Date
28-04-2024
Images
No images available.
Geographical location(s)
